Track RVL Pharmaceuticals plc Ordinary Shares — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

RVL Pharmaceuticals plc Ordinary Shares RVLP · Stock Open RVL Pharmaceuticals plc Ordinary Shares in new tab

0.0282 USD
Add to portfolio
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for RVL Pharmaceuticals plc Ordinary Shares (RVLP)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

RVL Pharmaceuticals plc Ordinary Shares Logo RVL Pharmaceuticals plc Ordinary Shares Analysis (RVLP)

United States Health Care Official Website Stock

Is RVL Pharmaceuticals plc Ordinary Shares a good investment? RVL Pharmaceuticals plc Ordinary Shares (RVLP) is currently trading at 0.0282 USD.

Investor FAQ

Does RVL Pharmaceuticals plc Ordinary Shares pay a dividend?

No, it does not currently pay a dividend.

What asset class is RVL Pharmaceuticals plc Ordinary Shares?

RVL Pharmaceuticals plc Ordinary Shares is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Exchange Ticker
NMS (United States) RVLP
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion